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SUMMARY. Alpinia officinarum has been used by long time in the traditional medicine and several com-
mercial extracts containing it are available on the market. In this paper a reversed phase high perfor-
mance liquid chromatography-diode array detection (RP-HPLC-DAD) method for Alpinia officinarum
preparations was proposed using galangin as a marker. The quantification was undertaken by a combina-
tion of RP-HPLC-DAD. The LC system employed a Gemini Phenomenex RP-18 column with phosphoric
acid, tetrahydrofuran and acetonitrile as mobile phase and detection at 267 nm. The method validation
was throughout satisfactory. The determination coefficient was r2 = 0.998 with LOD 0.48 μg mL–1 and
LOQ 1.59 μg mL–1. The results of precision (RSD < 2.82) and accuracy (99.9 %, 100.4 %, 102.2 %) with
RSD less than 2.7 %, were satisfactory. The analytical method was applied to commercial extracts, and
was suitable to provide qualitative and quantitative information for the quality control to commercial
preparations. 
